Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.

Abstract

The aim of the present study was to determine serum levels of neutrophil gelatinase-associated lipocalin (NGAL) and leptin in patients with chronic myeloid leukemia (CML) at diagnosis and after imatinib therapy when patients achieved a complete molecular remission. The study was conducted on 22 patients with CML in the chronic phase and 10 healthy subjects… (More)
DOI: 10.1159/000330948

Topics

Cite this paper

@article{Alonci2012ImatinibMT, title={Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.}, author={Andrea Alonci and Alessandro Allegra and Sabina Russo and Giuseppa Penna and Giacomo Bellomo and Arianna D'angelo and Salvatore Campo and Antonino Cannav{\`o} and Raffaella Centorrino and Caterina Musolino}, journal={Acta haematologica}, year={2012}, volume={127 1}, pages={1-6} }